← All indications
Brain Diseases, Metabolic
Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
Subtype terms (8)
More specific conditions that are subtypes of Brain Diseases, Metabolic in the MeSH hierarchy.
- Brain Diseases, Metabolic, Inborn
1 drug experimental
- Hepatic Encephalopathy
76 drugs (42 approved, 34 experimental)
- Kernicterus
1 drug approved
- Marchiafava-Bignami Disease
- Mitochondrial Encephalomyopathies
4 drugs (2 approved, 2 experimental)
- Myelinolysis, Central Pontine
- Reye Syndrome
- Wernicke Encephalopathy
7 drugs approved
Drugs by status
Phase 2 trials (1)
Organizations
Organization Involved with Phase 1 Indications (2)